- Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis2017 | 1. lékařská fakulta
- Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry2017 | 1. lékařská fakulta
- Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma2012 | 1. lékařská fakulta
- Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study2017 | 1. lékařská fakulta
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE) : a multicentre, randomised, 24-month, phase 3 trial2019 | 1. lékařská fakulta
- Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy2017 | 1. lékařská fakulta
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial2019 | 1. lékařská fakulta
- Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a2021 | 1. lékařská fakulta
- Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial2016 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Alemtuzumab long-term immunologic effect Treg suppressor function increases up to 24 months2016 | 1. lékařská fakulta
- Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings2017 | 1. lékařská fakulta
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer2017 | Lékařská fakulta v Hradci Králové
- Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study2015 | 1. lékařská fakulta
- Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS2016 | 1. lékařská fakulta
- Tolerability and Safety of the New Anti-Obesity Medications2014 | 3. lékařská fakulta